Methixene hydrochloride as an EEG activating agent.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000679:Amygdala / Q000473:pathology; D001254:Astrocytoma; D001932:Brain Neoplasms; D002493:Central Nervous System Diseases; D002540:Cerebral Cortex / Q000187:drug effects*; D002908:Chronic Disease; D004569:Electroencephalography; D004594:Electrophysiology; D004833:Epilepsy, Temporal Lobe; D005260:Female; D006801:Humans; D008297:Male; D001523:Mental Disorders; D008875:Middle Aged; D010276:Parasympatholytics / Q000494:pharmacology*; D010880:Piperidines / Q000494:pharmacology*; D013702:Temporal Lobe / Q000187:drug effects
D010276:Parasympatholytics; D010880:Piperidines